Pentwater Capital Management’s Surgery Partners SGRY Stock Holding History

Pentwater Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$195M	Sell	11,630,000 -1,025,000	-8%	-$14.4M	1.19%	19
2026 Q1	$151M	Buy	12,655,000 +2,655,000	+27%	+$38.1M	0.78%	29
2025 Q4	$155M	Sell	10,000,000 -1,681,000	-14%	-$30.9M	0.81%	22
2025 Q3	$253M	Buy	11,681,000 +4,681,000	+67%	+$104M	1.41%	19
2025 Q2	$156M	Buy	7,000,000 +4,258,000	+155%	+$94.6M	1.01%	21
2025 Q1	$65.1M	Buy	2,742,000 +2,317,000	+545%	+$54.8M	0.55%	31
2024 Q4	$9M	Buy	+425,000	New	+$11.2M	0.1%	60

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pentwater Capital Management's SGRY Position: Q2 2026 in Review

Pentwater Capital Management reduced its Surgery Partners (SGRY) stake by 8.1% in Q2 2026, selling an estimated $14.4M and leaving 11,630,000 shares worth $195M. The position accounts for 1.19% of the portfolio, ranked #19.

Pentwater Capital Management first reported a position in SGRY in Q4 2024 and has held it in 7 quarters since. The position peaked at $253M in Q3 2025. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

Pentwater Capital Management held 11,630,000 shares of Surgery Partners worth $195M as of Q2 2026.
Pentwater Capital Management sold 1,025,000 Surgery Partners shares in Q2 2026, an estimated $14.4M.
Surgery Partners made up 1.19% of Pentwater Capital Management's portfolio in Q2 2026, its #19 holding.
Pentwater Capital Management first reported a position in Surgery Partners in Q4 2024 and has held it in 7 quarters since.
Pentwater Capital Management's Surgery Partners position peaked at $253M in Q3 2025.
187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.